SCHEMBL3334816

SCHEMBL3334816

[CH2]C=CC1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3148431 1.00
SCHEMBL3853318 0.97
SCHEMBL3853315 0.97
SCHEMBL4203486 0.83
SCHEMBL4203483 0.83
SCHEMBL8155752 0.79 ALDH1A1 (0.33)
SCHEMBL1305017 0.79 ALDH1A1 (0.33)
SCHEMBL6049736 0.79 ALDH1A1 (0.33)
SCHEMBL1305019 0.79 ALDH1A1 (0.33)
SCHEMBL11324624 0.79 ALDH1A1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140828-B1 3-AZABICYCLO¬3.1.0|HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS PFIZER LTD (GB) 2006-08-09 EP claimed
US-20030013875-A1 3-azabicyclo[3.1.0]hexane derivatives useful in therapy PFIZER, INC. (US) 2003-01-16 US claimed
US-20020072616-A1 3-azabicyclo[3.1.0]hexane derivatives useful in therapy PFIZER INC. 2002-06-13 US claimed
CN-1334809-A Non-steroidal anti-inflammatory drugs SCHERING AG (DE) 2002-02-06 CN claimed
US-6323199-B1 AROMATIC HETEROCYCLIC HYDROXY AMINES OR AMIDES FOR TREATMENT OF INFLAMMATION SCHERING AKTIENGESELLSCHAFT (DE) 2001-11-27 US claimed
US-6313312-B1 OPIATE RECEPTOR BINDERS; ALLERGIC DERMATITIS, PRURITUS; IRRITABLE BOWEL SYNDROME, GASTROINTESTINAL AND SKIN DISORDERS; VETERINARY MEDICINE; ANTI-ITCHING PFIZER INC 2001-11-06 US claimed
EP-1140828-A1 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS Pfizer Limited (GB) 2001-10-10 EP claimed
WO-2000039089-A1 3-AZABICYCLO[3.1.0.] HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS PFIZER LIMITED (GB) 2000-07-06 WO claimed
EP-0205834-B1 7-THIABICYCLOHEPTANE SUBSTITUTED ETHERS E.R. Squibb &amp; Sons, Inc. (US) 1990-10-31 EP claimed
US-20100152261-A1 NOVEL NITROGEN-CONTAINING HETEROCYCLIC COMPOUND MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-17 US disclosed
CN-100445272-C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity SCHERING AG (DE) 2008-12-24 CN disclosed
CN-100402570-C Polyvinyl alcohol block copolymer, and aqueous pigment dispersion and recording fluid using same MITSUBISHI CHEM CORP (JP) 2008-07-16 CN disclosed
EP-1939183-A1 NOVEL NITROGENATED HETEROCYCLIC COMPOUND Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-02 EP disclosed
US-7348382-B2 Polyvinyl alcohol based block copolymer and pigment dispersion aqueous liquid using the same and recording liquid MITSUBISHI CHEMICAL CORPORATION (JP) 2008-03-25 US disclosed
WO-1998002423-A1 PROCESS FOR PREPARING 1-SUBSTITUTED 4-CYANO-1,2,3-TRIAZOLES NOVARTIS AG (CH) 1998-01-22 WO disclosed
EP-0800516-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1997-10-15 EP disclosed
WO-1996020172-A1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED β-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME NIPPON STEEL CORPORATION (JP) 1996-07-04 WO disclosed
US-5211739-A Herbicidal-1-(disubstituted carbamoyl or thiocarbamoyl)-1,2,4-triazol-3-yl sulfonates and thisulfonates ROHM AND HAAS COMPANY (US) 1993-05-18 US disclosed
EP-0205834-B1 7-THIABICYCLOHEPTANE SUBSTITUTED ETHERS E.R. Squibb &amp; Sons, Inc. (US) 1990-10-31 EP disclosed
US-4242507-A Sulfonic acid esters FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1980-12-30 US disclosed